Karakus Nevin, Kara Nurten, Ulusoy Ali Naki
Department of Medical Biology and Genetics, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
DNA Cell Biol. 2008 Aug;27(8):449-52. doi: 10.1089/dna.2007.0724.
The 3' untranslated region (3'UTR) of the prohibitin gene has a positive effect on arresting cell proliferation between G1 and S phases and inhibits DNA synthesis. A C-to-T transition within this region creates a variant that alters mRNA function and has been shown to be associated with an increased breast cancer risk among young North Americans who are under 50 years and have at least one first-degree relative with breast cancer. We carried out a population-based case-control study to assess whether this association exists in Turkish women. We examined 106 breast cancer patients and 154 healthy controls by PCR and restriction fragment length polymorphism analysis. In the prohibitin 3'UTR, we did not detect a difference in CT/TT genotype frequency (p = 0.694; odds ratio [OR], 1.106; 95% confidence intervals [CI], 0.659-1.86) or in C/T allele frequency (p = 0.850; OR, 1.043; 95% CI, 0.667-1.62) between the all breast cancer patients and the controls. The results did not change in subgroups defined by age or family history. Hence our results do not lend support to the hypothesis that this polymorphism contributes to risk of breast cancer. The prohibitin T variant is not associated with the risk of breast cancer in Turkish women.
抑制素基因的3'非翻译区(3'UTR)对细胞在G1期和S期之间的增殖具有抑制作用,并能抑制DNA合成。该区域内的一个C到T的转换产生了一种改变mRNA功能的变体,并且已被证明与50岁以下且至少有一位患乳腺癌的一级亲属的北美年轻女性患乳腺癌风险增加有关。我们开展了一项基于人群的病例对照研究,以评估这种关联在土耳其女性中是否存在。我们通过聚合酶链反应(PCR)和限制性片段长度多态性分析对106例乳腺癌患者和154名健康对照进行了检测。在抑制素3'UTR区域,我们未检测到所有乳腺癌患者与对照组之间CT/TT基因型频率存在差异(p = 0.694;比值比[OR],1.106;95%置信区间[CI],0.659 - 1.86),也未检测到C/T等位基因频率存在差异(p = 0.850;OR,1.043;95% CI,0.667 - 1.62)。在按年龄或家族史定义的亚组中,结果没有变化。因此,我们的结果不支持这种多态性会增加乳腺癌风险这一假设。抑制素T变体与土耳其女性患乳腺癌的风险无关。